Unanswered clinical questions and speculation about the role of anti–immunoglobulin E in atopic and nonatopic disease

ISSN： 1539-6304

Source： Allergy and Asthma Proceedings, Vol.27, Iss.2, 2006-03, pp. : 37-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unanswered Questions and Warnings Involving Anti–Immunoglobulin E Therapy Based on 2-Year Observation of Clinical Experience

By Lanier Bob Q.

Allergy and Asthma Proceedings, Vol. 26, Iss. 6, 2005-11 ,pp. : 435-439

OceanSide Publications, Inc

Access to resources Recommend Favorite

Treatment of asthma with anti–immunoglobulin E monoclonal antibody

By Liu Andrew H.

Allergy and Asthma Proceedings, Vol. 27, Iss. 2, 2006-03 ,pp. : 24-28

OceanSide Publications, Inc

Access to resources Recommend Favorite

Mechanisms of action of anti–immunoglobulin E therapy

By Soresi Simona Togias Alkis

Allergy and Asthma Proceedings, Vol. 27, Iss. 2, 2006-03 ,pp. : 15-23

OceanSide Publications, Inc

Access to resources Recommend Favorite

Anti–immunoglobulin E monoclonal antibody administered with immunotherapy

By Parks Kevin W. Casale Thomas B.

Allergy and Asthma Proceedings, Vol. 27, Iss. 2, 2006-03 ,pp. : 33-36

OceanSide Publications, Inc

Access to resources Recommend Favorite

What Is New in Anti–Immunoglobulin E Asthma Therapy

By Berger William E.

Allergy and Asthma Proceedings, Vol. 26, Iss. 6, 2005-11 ,pp. : 428-434

OceanSide Publications, Inc

Access to resources Recommend Favorite